We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Sues Aurobindo Pharma Over Proposed Generic Prostate Cancer Drug
J&J Sues Aurobindo Pharma Over Proposed Generic Prostate Cancer Drug
Johnson & Johnson (J&J) has filed a complaint against Aurobindo Pharma charging the Indian generics maker with infringing on patents for J&J’s blockbuster prostate cancer therapy Erleada (apalutamide).